...
首页> 外文期刊>American Journal of Physiology >Inhibition of vascular smooth muscle cell proliferation by chronic hemin treatment
【24h】

Inhibition of vascular smooth muscle cell proliferation by chronic hemin treatment

机译:慢性血红素治疗抑制血管平滑肌细胞增殖

获取原文
获取原文并翻译 | 示例

摘要

First published July 11, 2008; doi:10.1152/ajpheart.01289.2007.-Hemin, an oxidized form of heme, is an essential regulator of gene expression and cell cycle progression. Our laboratory previously reported (34) that chronic hemin treatment of spontaneously hypertensive rats reversed the eutrophic inward remodeling of small peripheral arteries. Whether long-term treatment of cultured vascular smooth muscle cells (VSMCs) with hemin alters the proliferation status of these cells has been unknown. In the present study, hemin treatment at 5 muM for 4, 7, 14, and 21 days significantly inhibited the proliferation of cultured rat aortic VSMCs (A-10 cells) by arresting cells atGo/Gi phases so as to decelerate cell cycle progression. Heme oxygenase (HO) activity and inducible HO-1 protein expression were significantly increased by hemin treatment. HO inhibitor tin protoporphyrin IX (SnPP) abolished the effects of hemin on cell proliferation and HO activity. Interestingly, hemin-induced HO-1 expression was further increased in the presence of SnPP. Hemin treatment had no significant effect on the expression of constitutive HO-2. Expression of p21 protein and the level of reactive oxygen species (ROS) were decreased by hemin treatment, which was reversed by application of SnPP. After removal of hemin from culture medium, inhibited cell proliferation and increased HO-1 expression in VSMCs were returned to control level within 1 wk. Transfection with HO-1 small interfering RNA significantly knocked down HO-1 expression and decreased HO activity, but had no effect on HO-2 expression, in cells treated with or without hemin for 7 days. The inhibitory effect of hemin on cell proliferation was abolished in HO-1 silenced cells. It is concluded that induction of HO-1 and, consequently, increased HO activity are responsible for the chronic inhibitory effect of hemin on VSMC proliferation. Changes in the levels of p21 and ROS might also participate in the cellular effects of hemin.
机译:首次发布于2008年7月11日; doi:10.1152 / ajpheart.01289.2007.-Hemin,血红素的一种氧化形式,是基因表达和细胞周期进程的重要调节剂。我们的实验室先前曾报道(34),慢性血红素治疗自发性高血压大鼠逆转了小周围动脉的富营养化内向重塑。用血红素对培养的血管平滑肌细胞(VSMC)进行长期治疗是否会改变这些细胞的增殖状态尚不清楚。在本研究中,以5μM的血红素处理4、7、14和21天可将细胞停在Go / Gi期,从而抑制细胞周期进程,从而显着抑制培养的大鼠主动脉VSMC(A-10细胞)的增殖。通过血红素处理,血红素加氧酶(HO)活性和可诱导的HO-1蛋白表达显着增加。 HO抑制剂原卟啉IX(SnPP)取消了血红素对细胞增殖和HO活性的影响。有趣的是,在SnPP存在下,血红素诱导的HO-1表达进一步增加。血红素处理对HO-2组成型的表达没有明显影响。血红素处理可降低p21蛋白的表达和活性氧(ROS)的水平,而应用SnPP可逆转p21蛋白的表达和活性氧的水平。从培养基中除去血红素后,VSMC中抑制的细胞增殖和HO-1表达的增加在1周内恢复到对照水平。在有或没有血红素处理7天的细胞中,用HO-1小干扰RNA转染可显着降低HO-1表达并降低HO活性,但对HO-2表达无影响。在HO-1沉默的细胞中,消除了血红素对细胞增殖的抑制作用。结论是,HO-1的诱导以及由此导致的HO活性增加是血红素对VSMC增殖的慢性抑制作用。 p21和ROS水平的变化也可能参与了血红素的细胞作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号